Items where authors include "Dass, S"
Up a levelArticle
Md Yusof, MY orcid.org/0000-0003-3131-9121, Arnold, J, Saleem, B et al. (5 more authors) (2023) Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study. The Lancet Rheumatology, 5 (2). e88-e98. ISSN 2665-9913
Pepple, S, Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755 et al. (5 more authors) (2022) Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome. ACR Open Rheumatology, 4 (8). pp. 689-699. ISSN 2578-5745
Ahmed, WUR, Bhatia, S, McLean, KA et al. (4545 more authors) (2022) Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery. BJS Open, 6 (1). zrab150. ISSN 2474-9842
Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755, Dass, S et al. (5 more authors) (2022) A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis. Frontiers in Immunology, 12. 803175. ISSN 1664-3224
Melville, AR, Yusof, Y, Fitton, J orcid.org/0000-0002-7795-8191 et al. (6 more authors) (2021) Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis. Rheumatology. ISSN 1462-0324
Hassan, SU, Md Yusof, MY, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab. Frontiers in Medicine, 7. 498. ISSN 2296-858X
Marzo-Ortega, H, Tan, AL orcid.org/0000-0002-9158-7243, Bissell, L-A et al. (4 more authors) (2020) Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic. The Lancet Rheumatology, 2 (7). E386-E387. ISSN 2665-9913
Yusof, MYM, Iqbal, K, Darby, M et al. (6 more authors) (2020) Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis. Rheumatology. ISSN 1462-0324
Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, DM et al. (7 more authors) (2019) Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 71 (11). pp. 1812-1823. ISSN 2326-5191
Mahmod, M, Pal, N, Rayner, J et al. (15 more authors) (2018) The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance, 20. 88. ISSN 1097-6647
Md Yusof, MY orcid.org/0000-0003-3131-9121, Kabia, A, Darby, M et al. (5 more authors) (2017) Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre. Rheumatology, 56 (8). pp. 1348-1357. ISSN 1462-0324
Fitch, G, Williams, K, Freeston, JE et al. (6 more authors) (2016) Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy. Journal of Cystic Fibrosis, 15 (4). e35-e40. ISSN 1569-1993
Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, Das, S et al. (5 more authors) (2015) Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases, 74 (9). pp. 1734-1738. ISSN 0003-4967
Vital, EM, Dass, S, Buch, MH orcid.org/0000-0002-8962-5642 et al. (2 more authors) (2015) An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial. Annals of the Rheumatic Diseases, 74 (6). pp. 1195-1201. ISSN 0003-4967
Conference or Workshop Item
Md. Yusof, MY, Arnold, J, Saleem, B et al. (5 more authors) (2022) OP0250 BREAKTHROUGH INFECTIONS AND PREDICTING SEVERE COVID OUTCOMES DURING RITUXIMAB THERAPY IN AUTOIMMUNE RHEUMATIC DISEASES. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Arnold, J, Vital, E, Dass, S et al. (5 more authors) (2021) A Personalised Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in Anca-Associated Vasculitis. In: EULAR 2021, 02-05 Jun 2021, Virtual.
Arnold, JE, Vital, EMJ, Dass, S et al. (5 more authors) (2021) P207 A proposal for individually tailored rituximab treatment based on clinical and B-cell biomarkers for remission maintenance in ANCA associated vasculitis. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Online.
Yusof, MYM, Vital, E, Dass, S et al. (5 more authors) (2013) Safety of rituximab for remission maintenance in relapsing anca–associated vasculitis: repeat cycles on clinical relapse are associated with low rates of hypogammaglobulinaemia. In: Annual European Congress of Rheumatology EULAR, 12-15 Jun 2013, Spain.
Proceedings Paper
Yusof, YM, Arnold, J, Saleem, B et al. (5 more authors) (2022) Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases. In: Arthritis and Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 1559-1560.
Md Yusof, MY orcid.org/0000-0003-3131-9121, Iqbal, K, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2016) Efficacy and Safety of Rituximab in Patients with Rheumatoid Arthritis-Related Bronchiectasis (RA-BR): Results from A Multicentre Cohort. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 996.
Md Yusof, MY orcid.org/0000-0003-3131-9121, Candelier, JB, Dass, S et al. (3 more authors) (2016) Validation of B Cell Depletion as A Predictor of Clinical Response and Efficacy of Retreatment of Non-Response in Rheumatoid Arthritis. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 731.
Fitch, G, Williams, K, Freeston, J et al. (3 more authors) (2015) Defining the cystic fibrosis arthropathy phenotype: A serological and imaging pilot study. In: Journal of Cystic Fibrosis. 38th European Cystic Fibrosis Conference, 10-13 Jun 2015, Brussels. Elsevier , S62-S62.